Leela Barham looks at the speediness of NICE’s technology appraisals and ongoing efforts to hit the target of NICE publishing ...

The first person to receive a transplant of a kidney from a pig has died almost two months after the procedure, although the ...

Monitoring of heart failure patients in their homes using a wearable developed by Analog Devices Inc (ADI) has shown in a new ...

Sanofi will invest more than €1 billion ($1.08 billion) in new bioproduction capacity at three manufacturing sites in France ...

The fear for shareholders is that a delay could mean that mRNA-1345 won’t be ready to roll out in the US in time for the ...

Three years after turning it down for being too expensive, NICE has backed the use of Pfizer’s Vyndaqel as a treatment for ...

Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC ...

The Immigration Salary List has replaced the Shortage Occupation List with a significant reduction of SOC Codes on the list.

The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T ...

At last month’s Reuters Pharma Europe conference in Barcelona, pharmaphorum’s Eloise McLennan sat down with Peter Stenico, ...

With 2024 well under way, influential conferences in London have given a barometer reading on the conditions in the European ...

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development ...